Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WST11-mediated VTP in Inoperable Cholangiocarcinoma
NCT00975039Phase 2Terminated
- Sponsor
- Steba Biotech
- Start
- Sep 2009
- Primary completion
- Jun 2011
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of padeliporfin VTP in cholangiocarcinoma (CCA), sponsored by Steba Biotech. Started Sep 2009; status: terminated.
02
Drugs
padeliporfin VTP
03
Conditions
cholangiocarcinoma (CCA)
Beyond the preview
Go deeper on NCT00975039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00975039.